|6 Months Ended|
Jun. 30, 2022
8. Shareholders’ Equity
The Company’s Board of Directors and the Company’s shareholders, at its reconvened 2020 Annual Meeting on February 25, 2022, approved an amendment to our Amended and Restated Articles of Incorporation to (i) increase the number of authorized shares of common stock from shares to shares.
During the three and six months ended June 30, 2022, the Company issued no shares of common stock.
During the three months ended March 31, 2021, the Company issued an aggregate of 27.8 million and (ii) 2,472,573 shares of common stock issued as the result of the exercise of certain outstanding warrants which generated gross proceeds of approximately $2.3 million as a result of the exercise of certain outstanding. shares of common stock comprised of (i) shares of common stock issued in connection with sales under its At-The-Market Program which generated gross proceeds of approximately $
Series C Non-Voting, Non-Convertible, Preferred Stock Dividend and Redemption
During the three months ended March 31, 2021, the Company provided a notice of redemption, to the holder of the Company’s Series C Preferred Stock to redeem all outstanding Series C Preferred Stock (which included the dividend of 5.6 million was paid on March 15, 2021 and all outstanding shares of Series C Preferred Stock were cancelled. shares paid on January 28, 2021 and any accrued dividends due through the redemption date of March 13, 2021). The Series C Preferred Stock redemption amount of approximately $
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef